A5062920642- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Renal and related cancers
- Testicular diseases and treatments
- Prostate Cancer Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Cardiac tumors and thrombi
- Biomedical and Chemical Research
- Cancer survivorship and care
- Advanced Radiotherapy Techniques
- Intraoperative Neuromonitoring and Anesthetic Effects
- Muscle and Compartmental Disorders
- Intraocular Surgery and Lenses
- Urologic and reproductive health conditions
- Sperm and Testicular Function
- Cancer Diagnosis and Treatment
- Genital Health and Disease
- Neuroblastoma Research and Treatments
Royal Brisbane and Women's Hospital
2021-2025
The University of Queensland
2021-2025
Wesley Hospital
2021-2024
Royal Marsden NHS Foundation Trust
2021
Royal Marsden Hospital
2021
Nambour General Hospital
2009
BackgroundAccurate primary staging of renal cancer with conventional imaging is challenging. Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) may serve to improve the accuracy staging.ObjectiveTo determine clinicopathological and management differences for staged PSMA PET/CT in comparison imaging.Design, setting, participantsWe conducted a retrospective cohort study scans performed incidental lesions at three sites Brisbane, Australia...
Objectives To estimate the cost effectiveness of local anaesthetic (LA) transperineal prostate biopsy (TPB) compared to general (GA) TPB, considering both hospital/health system and societal perspectives. Patients Methods Individual‐patient data from a prospective pilot study 80 patients who underwent LA ( n = 40) or GA TPB according patient preference was used. A cost‐effectiveness analysis conducted using decision tree model cancer detection rates, perioperative return work considerations...
Abstract Purpose There is an emerging role of the use Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in renal cell carcinoma. Herein, we report our experience PSMA PET recurrent or metastatic carcinoma (RCC). Methods A retrospective analysis all patients who underwent for suspected de-novo RCC between 2015 and 2020 at three institutions was performed. The primary outcome change management (intensification de-intensification) following scan. Secondary outcomes...
Retroperitoneal lymph node dissection (RPLND) is essential for the treatment of metastatic germ cell tumours testis. Recommendations on referral and management complex urological cancers in UK includes centralisation services to regional centres.To review contemporary PC-RPLND outcomes at a high-volume centre with case-mix, compare national registry data.We retrospectively reviewed medical records PC-RPLNDs performed our between July 2012 September 2018.Primary were Clavien 3+ complications,...
Prostate cancer, the most common cancer among men worldwide, has significant impact on quality of life. Supportive care needs for those affected by prostate are not well understood. This study aims to describe patient-reported unmet and explore supportive priorities treated cancer.
Introduction Despite the excellent long-term prognosis after treatment for testicular cancer (TCa), therapy-related side effects can be persistent and severe. The aim of this study was to determine nature prevalence post-treatment symptoms their impact on health-related quality life (HRQoL) in TCa patients 12 24 months treatment. Materials methods Cross-sectional, single-center study. All who were aged 18 over, had completed 12–24 previously no evidence disease recurrence considered...
Late relapse (LR) of nonseminomatous germ cell tumour (NSGCT) is uncommon, with limited data published. LR defined as occurring after a disease-free interval 2 yr.To review features NSGCT in UK tertiary centre.A total 3064 patients were referred from January 2005 to December 2017. We identified who experienced initial pathology demonstrated and reviewed for their original presentation management.Outcomes included time measured the date diagnosis, overall survival. This was assessed using Cox...
529 Background: Late relapses (LR) of non-seminomatous germ cell tumours (NSGCT), defined as those occurring after a disease free interval 2 years, are increasingly recognised. We reviewed the features LR in NSGCT within tertiary referral testicular cancer service. Methods: 3,064 patients (pts) were referred to testis multi-disciplinary team (January 2005 Dec 2017). Pts who experienced where initial pathology demonstrated identified. Data their original and late presentation management was...
4540 Background: There is emerging role of the use PSMA PET in RCC. Herein, we report our experience recurrent or metastatic RCC Brisbane, Australia. Methods: Patients (pts) who underwent and conventional diagnostic CT for between 2015 2020 at three institutions were identified. Retrospective chart reviews conducted using standardized collection template. The outcomes included percentage patients had a change management secondary to findings, comparison metastasis detection vs. CT, biopsy...